[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:gastroesophageal-junction-adenocarcinoma:claudin-18-isoform-a2":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Gastroesophageal Junction Adenocarcinoma","Claudin-18 Isoform A2",7,[8,16,23,29,36,42,48],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06901531","A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer",[12],"Phase 3","RECRUITING","2026-08-26T02:18:33.598205Z","2026-07-05T05:32:16.705484Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05365581","A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer",[20],"Phase 1","2026-08-26T02:17:42.501124Z","2026-07-05T05:32:16.805238Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07431281","Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2",[12],"2026-08-26T02:16:04.914942Z","2026-05-05T02:43:29.651140Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT07069712","A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma",[33],"Phase 2","2026-08-26T02:19:12.219640Z","2026-05-05T02:43:28.835650Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06219941","AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2",[33],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:27.246686Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT07546812","Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas",[33],"2026-08-26T02:16:10.529598Z","2026-07-19T19:36:05.144248Z",{"nct_id":49,"title":50,"phases":51,"status":53,"updated_at":54,"content_modified":55},"NCT06921928","Study for AZD4360 in Participants With Advanced Solid Tumours",[52],"Phase 1\u002FPhase 2","ACTIVE_NOT_RECRUITING","2026-08-03T03:01:15.394071Z","2026-04-29T02:57:57.154395Z"]